Skip to main content

Table 2 Clinical characteristics of patients included for postmortem studies

From: Endotoxin- and ATP-neutralizing activity of alkaline phosphatase as a strategy to limit neuroinflammation

Patient

Gender

Age at death (years)

Disease duration (years)

MS disease form

Cause of death

NDC1

Male

73

NA

NA

Colon carcinoma with liver metastases

NDC2

Female

90

NA

NA

Unknown

NDC3

Female

68

NA

NA

Metastasized mamma carcinoma

NDC4

Male

84

NA

NA

Heart failure by uremia

MS1

Female

41

11

SP

Natural death

MS2

Female

50

17

Chronic progressive

Euthanasia

MS3

Female

55

21

SP

Possible CVA

MS4

Male

64

34

PP

End-stage progressive MS

MS5

Female

76

34

SP

Respiratory insufficiency of unknown origin

  1. CVA, cerebrovascular accident; MS, multiple sclerosis; NA, not applicable; PP, primary progressive; SP, secondary progressive.